Fig. 2. Subgroup analysis of patients with AML according to the different definitions of AML-MR in the WHO 2017, WHO 2022, and ICC guidelines and the introduction of AML with mutated TP53 in the ICC.
Abbreviations: ICC, International Consensus Classification; MR, myelodysplasia-related; AML-MR(C), AML-MR or AML-MRC; AML-MRC, AML with MR changes; HR, hazard ratio; CI, confidence interval; AML-TP53, AML with mutated TP53; AML-NOS, AML not otherwise specified; AML-DBD, AML defined by differentiation.

Ann Lab Med 2025;45:170~177 https://doi.org/10.3343/alm.2024.0194